Edition:
United Kingdom

Aspen Technology Inc (AZPN.OQ)

AZPN.OQ on NASDAQ Stock Exchange Global Select Market

67.29USD
17 Nov 2017
Change (% chg)

$0.55 (+0.82%)
Prev Close
$66.74
Open
$66.59
Day's High
$67.47
Day's Low
$66.47
Volume
145,619
Avg. Vol
177,967
52-wk High
$68.10
52-wk Low
$51.47

Chart for

About

Aspen Technology, Inc. is a global provider of process optimization software solutions designed to manage and optimize plant and process design, operational performance, and supply chain planning. The Company's aspenONE software and related services have been developed specifically for companies in the process industries,... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $4,730.98
Shares Outstanding(Mil.): 73.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 19.64 16.41
EPS (TTM): -- -- --
ROI: -- 16.07 10.66
ROE: -- 18.17 14.26

BRIEF-Aspen Technology Q1 non-GAAP earnings per share $0.53

* Aspen technology announces financial results for the first quarter of fiscal 2018

26 Oct 2017

UK anti-trust regulator investigates South Africa's Aspen Pharmacare

JOHANNESBURG Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

13 Oct 2017

UK anti-trust regulator investigates S.Africa's Aspen Pharmacare

JOHANNESBURG, Oct 13 Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

13 Oct 2017

South Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

04 Oct 2017

UPDATE 1-S.Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG, Oct 4 South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

04 Oct 2017

S.Africa watchdog drops over-charging probe into Aspen, Equity

JOHANNESBURG, Oct 4 South Africa's competition watchdog has dropped an investigation into Aspen Pharmacare and Equity Pharmaceutical, saying a case against them for over-charging for cancer medicines "cannot be sustained."

04 Oct 2017

CORRECTED-South Africa's Aspen Pharmacare flags jump in full-year profit

JOHANNESBURG, Aug 30 South African drugmaker Aspen Pharmacare said on Wednesday that it expects full-year profit to climb by as much as 48 percent from last year when it was hit by a writedown on its Venezuelan business.

30 Aug 2017

BRIEF-Aspen Technology Q4 non-GAAP earnings per share $0.79

* Aspen Technology announces financial results for the fourth quarter and fiscal year 2017

10 Aug 2017

Earnings vs. Estimates